Urinalysis Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Consumables and Instruments), Test Type (Pregnancy and Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis), Application (Disease Screening, and Pregnancy and Fertility), and End-User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, Research Laboratories, and Institutes), and Geography
Publication Month: Oct 2021 | Report Code: TIPHE100001381 | No. of Pages: 195 | Category: Medical Device | Status: Published
The urinalysis market is projected to reach US$ 5,937.97 million by 2028 from US$ 4,065.79 million in 2021; it is expected to grow at a CAGR of 5.6% from 2021 to 2028.
A urinalysis is used in the diagnosis and management of various disorders such as kidney disease, urinary tract infections, and diabetes. It is the analysis of urine by chemical, physical, and microscopical means to check for the presence of drugs and disease-related entities, including biomolecules or other by-products, in it. The urinalysis includes checking the concentration, appearance, and content of urine. In urinalysis, abnormal results or estimations out of the expected range may indicate an illness or disease. If the urine test result is positive, it may point that kidneys are not functioning or filtering the blood in the manner as they should. It might also help in the diagnosis of cardiovascular disease, and detection of pregnancy and ovulation.
Report Coverage
The urinalysis market has been segmented on the basis of product, test type, application, end user, and geography. Based on geography, the market is primarily segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The report offers insights and in-depth analysis of the urinalysis market, emphasizing parameters such as market trends, technological advancements, and market dynamics, along with competitive landscape analysis of the globally leading market players.
Lucrative Regions for Urinalysis Market
Get more information on this report :
Market Insights
Growing Burden of Urinary Tract Infection, Diabetes, and Kidney Diseases Boosts Urinalysis Market Growth
As per the study reported by a group of researchers at the American College of Physicians and Infectious Diseases Society of America in 2020, ~6 million people in the US visit physicians for the treatment of urinary tract infection (UTIs) every year. Women are at a higher risk of developing UTIs than men. According to a study published in the International Journal of Environmental Research and Public Health in 2019, patients with existing chronic conditions, such as diabetes mellitus (DM), are at a greater risk of acquiring UTIs. The demand for components required for urinalysis is rising due to the common occurrence of diabetes across the world, as the primary screening for diabetes involves urinalysis. As per the International Diabetes Federation (IDF), ~463 million adults (age 20–79 years) in the world were living with diabetes in 2019; this number is likely to rise to 700 million by 2045. According to the IDF, ~87.6 million adults of age 20–79 was living with diabetes in Southeast Asia in 2019, representing a regional prevalence of 8.8%, and ~56.7% of these diabetes cases were undiagnosed, this shows there is potential for market development of urinalysis. Moreover, according to a study published by the National Kidney Foundation in 2020, ~35.0% of the diabetic population above age 20 would develop chronic kidney diseases over the period. An ongoing surge in the prevalence of prostate and bladder cancer raises a strong therapeutic imperative for the implementation of highly effective diagnostics.
Thus, the escalating prevalence of UTIs, diabetes, and kidney diseases boosts urinalysis market growth.
Product-Based Insights
Based on product, the urinalysis market is segmented into consumables and instruments. The consumables segment is expected to hold a larger market share in 2021, and it is further anticipated to register a higher CAGR during the forecast period.
Urinalysis Market, by Product – 2021 and 2028
Get more information on this report :
Test Type-Based Insights
The urinalysis market, based on test type, is segmented into pregnancy and fertility tests, biochemical urinalysis, and sediment urinalysis. The biochemical urinalysis segment would hold the largest share of the market in 2021, and it is estimated to register the highest CAGR in the market during 2021–2028.
Application-Based Insights
Based on application, the urinalysis market is segmented into disease screening and pregnancy, and fertility. The disease screening segment would account for a larger market share in 2021. The market for the same segment is estimated to grow at a higher CAGR from 2021 to 2028.
End User-Based Insights
The urinalysis market, by end user, is segmented into hospitals and clinics, diagnostic laboratories, home care settings, and research laboratories and institutes. The hospitals and clinics segment would hold the largest share of the market in 2021, while the diagnostic laboratories segment is estimated to register the highest CAGR during the forecast period.
COVID-19 has presented the most significant global health emergency till date. Lockdowns resulting from the COVID-19 pandemic caused people to delay undergoing health checkups, thus affecting the number of tests being performed and sales of instruments, consumables, and reagents. The urinalysis market witnessed a shortfall at the beginning of the COVID-19 crisis due to disruption in supply chain and demand due to the lockdown announced by most European countries. However, a resurgence in testing numbers is seen as countries gradually ease restrictions on movement.
Acquisitions, collaborations, partnerships, product launches, and expansions are commonly adopted strategies by companies to expand their footprint worldwide and meet the growing demand. The urinalysis market players have been chiefly adopting the strategy of product innovation to cater to the changing customer demands across the world, which also helps them maintain their brand name globally.
Company Profiles
- Abbott
- ACON Laboratories, Inc.
- ARKRAY, Inc.
- Beckman Coulter, Inc.
- Bio-Rad Laboratories Inc.
- Cardinal Health Inc
- F. Hoffmann-La Roche Ltd.
- Quidel Corporation
- Siemens Healthineers AG
- Sysmex Corporation
Frequently Asked Questions
The List of Companies - Urinalysis Market
- Abbott
- ACON Laboratories, Inc.
- ARKRAY, Inc.
- Beckman Coulter, Inc.
- Bio-Rad Laboratories Inc.
- Cardinal Health Inc
- F. Hoffmann-La Roche Ltd.
- Quidel Corporation
- Siemens Healthineers AG
- Sysmex Corporation
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Urinalysis market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global Urinalysis market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount